December 16, 2018
“Diagnostic labelling” harms targeted therapy research in airways disease. We make a call to adopt the “treatable trait” approach with our latest publication in the European Respiratory Journal: http://erj.ersjournals.com/content/52/6/1802218
Shrimanker R, Beasley R, Kearns C. Letting the right one in: evaluating the generalisability of clinical trials. Eur Respir J 2018; 52: 1802218 [https://doi.org/10.1183/13993003.02218- 2018].